AP
XENT

Americana Partners’s Intersect ENT, Inc XENT Stock Holding History

Americana Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-65,566
Closed -$887K – 99
2020
Q2 		$887K Hold
65,566
– – 0.67% 32
2020
Q1 		$776K Hold
65,566
– – 0.79% 34
2019
Q4 		$1.63M Buy
+65,566
New +$1.33M 0.91% 24

Other funds holding XENT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Americana Partners's XENT Position: Q3 2020 in Review

Americana Partners sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 65,566 shares — an estimated $887K sold.

Americana Partners first reported a position in XENT in Q4 2019 and held it in 3 quarters. The position peaked at $1.63M in Q4 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

  • Americana Partners reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
  • Americana Partners sold 65,566 Intersect ENT, Inc shares in Q3 2020, an estimated $887K.
  • Americana Partners first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 3 quarters.
  • Americana Partners's Intersect ENT, Inc position peaked at $1.63M in Q4 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on Americana Partners's 13F filing for Q3 2020, filed 26 Oct 2020.